Using Ultrasound Spectrum Analysis (USA) to Guide Dose Escalated Prostate Brachytherapy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Clinical Stage T2b or Less of Prostate CancerProstate BrachytherapyTransrectal Prostate Ultrasound Treatment Planning
Interventions
OTHER

An ultrasound-based technique to identify prostate cancer

The technique uses current ultrasound equipment already in use for prostate brachytherapy guidance.By extracting and processing the radiofrequency signal obtained from the ultrasound transducer in ways not done to create the standard B-mode ultrasound image, areas of cancer can be identified and displayed overlying the standard B-mode ultrasound image. Comparing the results with this technique to the results of prostate biopsies demonstrates a high degree of accuracy with the area under the receiver-operator characteristic curve of 0.87, a result superior to any other imaging methods.

OTHER

pre-implant transrectal ultrasound images and planning

an ultrasound-based technique to identify cancer-containing areas within the prostate.

OTHER

ultrasound-based cancer-specific images

ultrasound-based cancer-specific images of the prostate prior to the brachytherapy and use them to direct the dosimetry planning

Trial Locations (1)

10019

St.Luke's-Roosevelt Hospital Center, New York

All Listed Sponsors
collaborator

Riverside Research Institute

OTHER

lead

Beth Israel Medical Center

OTHER

NCT01227642 - Using Ultrasound Spectrum Analysis (USA) to Guide Dose Escalated Prostate Brachytherapy | Biotech Hunter | Biotech Hunter